Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vext Science Inc C.VEXT

Alternate Symbol(s):  VEXTF

Vext Science, Inc. is a cannabis operator. The Company’s expertise spans from cultivation through to retail operations in markets of Arizona and Ohio. It manufactures THC cartridges, concentrates, edibles and accessories under the Vapen brand, and hemp-based products under the Pure Touch Botanicals brand as well as the Vapen CBD and Herbal Wellness brands. It has THC concentrates, edibles, and distillate cartridge brands sold in various states dispensaries. It owns and operates cultivation facilities, fully built-out manufacturing facilities as well as dispensaries in both Arizona and Ohio. Additionally, it provides management, advisory, cultivation, and dispensary services to entities in the cannabis field through joint operations agreements. It also sells CBD products and branded merchandise. Vapen Brands product is the wholesale product and sold in its dispensaries. Vapen Brand is an edible and concentrate brand. The Company also owns cannabis dispensary in Columbus, Ohio.


CSE:VEXT - Post by User

Post by retiredcfon Jul 15, 2021 10:36am
150 Views
Post# 33548982

More BNN

More BNN

We see the pathway to larger cannabis reforms in the U.S.: Eight Capital analyst

Graeme Kreindler, analyst at Eight Capital discusses the U.S. draft legislation on legalizing cannabis at a federal level. He dives into how this will affect investors looking to participate in the cannabis space and outlines what this legislation would mean for the cannabis industry.

https://www.bnnbloomberg.ca/video/we-see-the-pathway-to-larger-cannabis-reforms-in-the-u-s-eight-capital-analyst~2241691

<< Previous
Bullboard Posts
Next >>